Limonin
Based on 13 publication(s) in Google Scholar
Limonin inhibits HIV-1 with an EC50 of 60.0 μM. Limonin induces human colon adenocarcinoma cells apoptosis with an IC50 of 54.74 μM. Limonin has antiviral and antitumor activities.
For research use only. We do not sell to patients.
- Purity: 99.38%
- CAS No.: 1180-71-8
- Formula: C26H30O8
- Molecular Weight:470.51
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Limonin
More- Br J Pharmacol. 2022 Sep;179(18):4516-4533. [Abstract]
- Biomed Pharmacother. 2020 Nov;131:110541. [Abstract]
- PLoS Biol. 2024 Jun 27;22(6):e3002672. [Abstract]
- Food Funct. 2025 Feb 3;16(3):1041-1059. [Abstract]
- Int Immunopharmacol. 2023 Sep:122:110678. [Abstract]
- Front Cell Dev Biol. 2021 Jun 11:9:684393. [Abstract]
- J Pharm Pharmacol. 2023 Apr 17;75(5):612-624. [Abstract]
- Vet Microbiol. 2026 May:316:110992. [Abstract]
- Vet Microbiol. 2025 Sep 15:310:110730. [Abstract]
- Immun Inflamm Dis. 2023 Feb;11(2):e787. [Abstract]
- PLoS One. 2026 Mar 16;21(3):e0343495. [Abstract]
- Theriogenology. 2025 Jan 15:232:96-108. [Abstract]
- bioRxiv. 2024 Apr 3:2023.06.02.542933. [Abstract]
-
WB
-
Cell Proliferation/Viability Assay
-
IF
-
ELISA
-
In Vivo Efficacy Study
All Endogenous Metabolite Isoforms
More
Biological Activity
|
HIV-1 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| H9 | IC50 |
2.11 ng/mL
Compound: Limonin
|
Inhibition of HIV1 3B reverse transcriptase activity infected in human H9 cells assessed as level of p24 antigen
Inhibition of HIV1 3B reverse transcriptase activity infected in human H9 cells assessed as level of p24 antigen
|
[PMID: 21334901] |
| MCF7 | IC50 |
4.3 μM
Compound: 11; LMN
|
Antiproliferative activity against human MCF7 cells incubated for 48 hrs by [3H]-thymidine incorporation assay
Antiproliferative activity against human MCF7 cells incubated for 48 hrs by [3H]-thymidine incorporation assay
|
[PMID: 33289552] |
| MDA-MB-435 | IC50 |
26 μM
Compound: 11; LMN
|
Antiproliferative activity against human MDA-MB-435 cells incubated for 48 hrs by [3H]-thymidine incorporation assay
Antiproliferative activity against human MDA-MB-435 cells incubated for 48 hrs by [3H]-thymidine incorporation assay
|
[PMID: 33289552] |
| MOLT-3 | CC50 |
201.56 μg/mL
Compound: Limonin
|
Cytotoxicity against human MOLT3 cells after 24 hrs by MTS assay
Cytotoxicity against human MOLT3 cells after 24 hrs by MTS assay
|
[PMID: 21334901] |
| MT2 | IC50 |
0.31 ng/mL
Compound: Limonin
|
Inhibition of Human T-cell leukemia/lymphoma virus type 1 reverse transcriptase activity infected in human MT2 cells assessed as level of p19 antigen
Inhibition of Human T-cell leukemia/lymphoma virus type 1 reverse transcriptase activity infected in human MT2 cells assessed as level of p19 antigen
|
[PMID: 21334901] |
| Neutrophil | IC50 |
38.2 μM
Compound: 14
|
Immunomodulatory activity in polymorphoneutrophils assessed as inhibition of luminol-induced oxidative burst by chemiluminescence assay
Immunomodulatory activity in polymorphoneutrophils assessed as inhibition of luminol-induced oxidative burst by chemiluminescence assay
|
[PMID: 18950230] |
| PBMC | CC50 |
451.91 μg/mL
Compound: Limonin
|
Cytotoxicity against PHA-stimutated human PBMC after 24 hrs by MTS assay
Cytotoxicity against PHA-stimutated human PBMC after 24 hrs by MTS assay
|
[PMID: 21334901] |
Limonin (100 μM) exhibits cytotoxic effect and inhibits SW480 cells proliferation [2].
Limonin (40 μM) inhibits HIV-1 protease in PBMC of HIV-1 infected patients[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SW480 cells
-
Concentration:25, 50, 75, 100 μM
-
Incubation Time:4, 6 days
-
Result:Inhibited cell proliferation by 89% at 4 days with 100 μM.
Inhibited cell proliferation by 75% at 6 days with 100 μM.
Chemical Information
-
CAS No. 1180-71-8
-
Appearance Solid
-
Molecular Weight 470.51
-
Formula C26H30O8
-
Color White to off-white
-
SMILES
O=C1[C@@H]2[C@@]3(O2)[C@](CC[C@@]([C@@]4([C@@](CC(OC4)=O)([H])OC5(C)C)[C@@]5([H])CC6=O)([H])[C@]36C)(C)[C@H](C7=COC=C7)O1
-
Synonyms
Limonoic acid 3,19:16,17 dilactone
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (13)
-
Journal Impact Factor
-
Most Recent
-
Br J Pharmacol
Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy. [Abstract]2022 Sep;179(18):4516-4533. PMID: 35727596 -
Biomed Pharmacother
Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody. [Abstract]2020 Nov;131:110541. PMID: 33152901 -
PLoS Biol
2024 Jun 27;22(6):e3002672. PMID: 38935621 -
Food Funct
Dietary limonin alleviates Salmonella Typhimurium-induced colitis via dual targeting virulence SopB and SopE2 and inhibiting RAC1/CDC42/Arp2/3 pathway and regulating gut microbiota. [Abstract]2025 Feb 3;16(3):1041-1059. PMID: 39820212 -
Int Immunopharmacol
2023 Sep:122:110678. PMID: 37481848 -
Front Cell Dev Biol
Licarin-B Exhibits Activity Against the Toxoplasma gondii RH Strain by Damaging Mitochondria and Activating Autophagy. [Abstract]2021 Jun 11:9:684393. PMID: 34179016 -
J Pharm Pharmacol
Limonin delays the progression of intervertebral disc degeneration in vivo and in vitro: the key role of the MAPK/NF-κB and necroptosis pathways. [Abstract]2023 Apr 17;75(5):612-624. PMID: 36856818 -
Vet Microbiol
The Chinese medicine monomer Schisandrin C inhibits PRRSV infection by regulating the OGT-PI3K/AKT/mTOR signaling pathway. [Abstract]2026 May:316:110992. PMID: 41865607 -
Vet Microbiol
Identification and evaluation of Nordihydroguaiaretic acid (NDGA) as an active traditional Chinese medicine compound inhibiting the 3C-like protease of feline infectious peritonitis virus. [Abstract]2025 Sep 15:310:110730. PMID: 40976146 -
Immun Inflamm Dis
Limonin ameliorates indomethacin-induced intestinal damage and ulcers through Nrf2/ARE pathway. [Abstract]2023 Feb;11(2):e787. PMID: 36840501
Limonin purchased from MedChemExpress. Usage Cited in: Immun Inflamm Dis. 2023 Feb;11(2):e787. [Abstract]
Limonin (40 mg/kg; p.o.; single daily for 4 days) significantly increases the expression of ZO-1, Occludin, and claudin-1 in small intestinal tissues of rats.
Limonin purchased from MedChemExpress. Usage Cited in: Immun Inflamm Dis. 2023 Feb;11(2):e787. [Abstract]
CCK8 was used to detect cell activity after treatment with different concentrations of Limonin (25, 50, 100 μM).
Limonin purchased from MedChemExpress. Usage Cited in: Immun Inflamm Dis. 2023 Feb;11(2):e787. [Abstract]
Apoptosis was detected by TUNEL assay treated with Limonin.
Limonin purchased from MedChemExpress. Usage Cited in: Immun Inflamm Dis. 2023 Feb;11(2):e787. [Abstract]
The levels of serum inflammatory factors were detected by ELISA treated with Limonin.
Limonin purchased from MedChemExpress. Usage Cited in: Immun Inflamm Dis. 2023 Feb;11(2):e787. [Abstract]
Photograph of the small intestine of rats treated with Limonin (40 mg/kg, p.o.).
Limonin purchased from MedChemExpress. Usage Cited in: Immun Inflamm Dis. 2023 Feb;11(2):e787. [Abstract]
Hematoxylin and eosin staining was used to detect the pathological damage of small intestinal tissues treated with Limonin (10, 40 mg/kg, p.o.).
-
PLoS One
Limonin induces ferroptosis in cervical squamous cell carcinoma by activating the expression of soluble epoxide hydrolase 2 protein. [Abstract]2026 Mar 16;21(3):e0343495. PMID: 41838669 -
Theriogenology
2025 Jan 15:232:96-108. PMID: 39536623 -
bioRxiv
An efficient behavioral screening platform classifies natural products and other chemical cues according to their chemosensory valence in C. elegans. [Abstract]2024 Apr 3:2023.06.02.542933. PMID: 37333363
Solvent & Solubility
DMSO : 41.67 mg/mL (88.56 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (4.42 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (287 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Han YL, Yu HL, Li D, et al. Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro. Toxicol In Vitro. 2011 Dec;25(8):1828-33. [Content Brief]
[4]. Battinelli L, Mengoni F, Lichtner M, et al. Effect of limonin and nomilin on HIV-1 replication on infected human mononuclear cells. Planta Med. 2003 Oct;69(10):910-3. [Content Brief]
[5]. Tanaka T, Kohno H, Tsukio Y, et al. Citrus limonoids obacunone and limonin inhibit azoxymethane-induced colon carcinogenesis in rats. Biofactors. 2000;13(1-4):213-8. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.1254 mL | 10.6268 mL | 21.2535 mL | 53.1338 mL |
| 5 mM | 0.4251 mL | 2.1254 mL | 4.2507 mL | 10.6268 mL | |
| 10 mM | 0.2125 mL | 1.0627 mL | 2.1254 mL | 5.3134 mL | |
| 15 mM | 0.1417 mL | 0.7085 mL | 1.4169 mL | 3.5423 mL | |
| 20 mM | 0.1063 mL | 0.5313 mL | 1.0627 mL | 2.6567 mL | |
| 25 mM | 0.0850 mL | 0.4251 mL | 0.8501 mL | 2.1254 mL | |
| 30 mM | 0.0708 mL | 0.3542 mL | 0.7085 mL | 1.7711 mL | |
| 40 mM | 0.0531 mL | 0.2657 mL | 0.5313 mL | 1.3283 mL | |
| 50 mM | 0.0425 mL | 0.2125 mL | 0.4251 mL | 1.0627 mL | |
| 60 mM | 0.0354 mL | 0.1771 mL | 0.3542 mL | 0.8856 mL | |
| 80 mM | 0.0266 mL | 0.1328 mL | 0.2657 mL | 0.6642 mL |